Biblio

Found 6 results

Filters: Author is Small, Eric Jay [Clear All Filters]

2016

E. Jay Small, Aggarwal, R. Raj, Huang, J., Sokolov, A., Zhang, L., Alumkal, J. J., Youngren, J., Ryan, C. J., Foye, A., Reiter, R. Evan, and , “Clinical and genomic characterization of metastatic small cell/neuroendocrine prostate cancer (SCNC) and intermediate atypical prostate cancer (IAC): Results from the SU2C/PCF/AACRWest Coast Prostate Cancer Dream Team (WCDT).”. American Society of Clinical Oncology, 2016.

2015

E. Jay Small, Huang, J., Youngren, J., Sokolov, A., Aggarwal, R. Raj, Thomas, G., True, L. D., Zhang, L., Foye, A., Alumkal, J. J., and , “Characterization of neuroendocrine prostate cancer (NEPC) in patients with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) or enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer ”. American Society of Clinical Oncology, 2015.

2014

E. Jay Small, Youngren, J., Thomas, G., Olson, S., Toschi, A., Foye, A., Alumkal, J. J., Rettig, M., Gleave, M. Edwin, Evans, C. P., and , “Androgen receptor (AR) amplification in patients with metastatic castration-resistant prostate cancer (mCRPC) refractory to therapy with abiraterone acetate or enzalutamide: Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team ”. American Society of Clinical Oncology, 2014.

J. J. Alumkal, Heiser, L., Beer, T. M., Small, E. Jay, Baertsch, R., Stuart, J., King, C., Korkola, J., Cetnar, J., Graff, J. Nicole, and , “Identifying enzalutamide resistance mechanisms in men with castration-resistant prostate cancer.”. American Society of Clinical Oncology, 2014.

E. Jay Small, Youngren, J., Beer, T. M., Ryan, C. J., Thomas, G., Pourmand, N., Reiter, R. Evan, Alumkal, J. J., Stuart, J. M., Evans, C. P., and , “The molecular and pathway characterization of patients with metastatic castration resistant prostate cancer (mCRPC) refractory to therapy with abiraterone acetate or enzalutamide: Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream”. American Society of Clinical Oncology, 2014.

2013

P. G. Febbo, Goldstein, T. C., Baertsch, R., Youngren, J., Newton, Y., Bivol, A., Small, E. Jay, and Stuart, J. M., “Identification of polo-like kinase 1 (PLK1) in aggressive prostate cancer by paradigm analysis.”. American Society of Clinical Oncology, 2013.